Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -93,226 | -57,621 | -24,402 | -76,925 | -55,498 |
| Depreciation Amortization | 349 | 155 | 60 | 213 | 157 |
| Accounts receivable | -8,705 | -1,335 | -791 | 168 | 107 |
| Accounts payable and accrued liabilities | 7,285 | 7,330 | 2,186 | -3,261 | -3,159 |
| Other Working Capital | 7,591 | 8,700 | 2,918 | -6,337 | -5,048 |
| Other Operating Activity | 8,041 | -1,828 | 379 | 9,987 | 8,092 |
| Operating Cash Flow | $-78,667 | $-44,599 | $-19,650 | $-76,156 | $-55,350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | -46 | -27 | -62 | -36 |
| Purchase Sale Intangibles | -20,749 | -435 | -142 | -765 | -440 |
| Other Investing Activity | -20,760 | -446 | -154 | -765 | -440 |
| Investing Cash Flow | $-20,827 | $-492 | $-181 | $-827 | $-476 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75,000 | 75,000 | N/A | N/A | 0 |
| Common Stock Issued | 91,144 | 1,129 | 44 | 72,584 | 72,584 |
| Other Financing Activity | -3,787 | -3,787 | 0 | 0 | 0 |
| Financing Cash Flow | $162,357 | $72,342 | $44 | $72,584 | $72,584 |
| Beginning Cash Position | 127,136 | 127,136 | 127,136 | 131,534 | 131,534 |
| End Cash Position | 189,999 | 154,387 | 107,350 | 127,136 | 148,293 |
| Net Cash Flow | $62,864 | $27,251 | $-19,786 | $-4,399 | $16,759 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,667 | -44,599 | -19,650 | -76,156 | -55,350 |
| Capital Expenditure | -66 | -46 | -27 | -62 | -36 |
| Free Cash Flow | -78,733 | -44,645 | -19,677 | -76,217 | -55,386 |